A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia. Issue 2 (23rd November 2020) - Zheng, Hong; Mineishi, Shin; Claxton, David; Zhu, Junjia; Zhao, Chenchen; Jia, Bei; Ehmann, W. Christopher; Rybka, Witold B.; Naik, Seema; Songdej, Natthapol; Drabick, Joseph J.; Hohl, Raymond J.